Pharmacy Report Archives - Page 4 of 137 - Becker's Hospital Review

Trump's drug pricing deals, explained | Medicaid Rx cost pilot: 8 details | Calif. system averts strike with pharmacists | Patient dies in gene therapy study | Pfizer wins Metsera bidding war

Pricing reforms and Medicaid pilots lead this week. November 10, 2025 1. CMS launches pilot to lower Medicaid drug costs: 8 things to know Full story 2. Trump administration's drug pricing deals, explained Full story 3. Pharmacy labor costs down…

Medicare to cover GLP-1s | Court OKs 340B contract pharmacies in Colo. | 10 systems seeking pharmacy leaders | Pfizer-Novo bidding war heats up: 5 notes | 3 drug, device recalls

Key 340B, pricing, recall updates for pharmacy leaders November 6, 2025 1. Medicare to cover GLP-1s under Trump-negotiated pricing Full story 2. Court rejects AbbVie's push to restrict 340B protections Full story 3. Hartford HealthCare is cutting nurse strain + improving…

Amid 14 new drug shortages, hospitals strive for fixes | Ballad unites Rx dispensing, IV compounding | Pharmacies fill data gaps | 81 systems with strong finances

From shortages to system strength — hospitals push for pharmacy stability. November 5, 2025 1. 14 drugs in shortage Full story 2. Hospitals strive for long-term fix to drug shortages Full story 3. Nebraska Medicine shares GenAI RCM wins live…

Pharmacy execs share 5-year plans | Pfizer sues Novo Nordisk, Metsera | 3 GLP-1 updates | The state of chemotherapy drug shortages | 20 best places to retire: US News

From long-term plans to supply strain — pharmacy’s challenges come into focus. November 4, 2025 1. How C-suite pharmacy leaders plan to thrive in the near future Full story 2. Pfizer sues Metsera, Novo Nordisk over failed merger Full story…

FDA's top drug regulator exits amid probe | 340B rebate pilot gains steam | 22 cancer drugs in shortage: 7 notes | 3 Joint Commission moves | Kleenex co. to buy Tylenol maker for $48.7B

From FDA shake-ups to 340B pilots — pharmacy leaders brace for change. November 3, 2025 1. FDA's top drug regulator resigns amid investigation Full story 2. HRSA to launch 340B rebate pilot with 8 drugmakers: 5 notes Full story 3.…

Pfizer, Novo Nordisk spar over NY drugmaker | Novant's pharmacy bet pays off | 10 systems seeking pharmacy leaders | Carcinogen spurs Teva drug recall | CVS reports $4B Q3 loss

From pharma rivalries to recalls — pressure mounts across the industry. October 30, 2025 1. Pfizer says Novo Nordisk's Metsera bid breaks law Full story 2. How Novant's bet on pharmacy is improving patient outcomes Full story 3. As essential…

FDA relaxes rules for biosimilar candidates | Ascension augments pharmacy techs with AI | Mark Cuban pharmacy: 3 updates | 10 best, worst states for jobs | Senators push FDA for stricter oversight

From AI-assisted techs to biosimilar reforms — innovation drives pharmacy forward. October 29, 2025 1. FDA rewrites biosimilar rules to slash drug costs Full story 2. How Ascension built pharmacy into the care continuum Full story 3. What essential hospitals…

Texas sues Tylenol makers | What hospitals need from pharma execs | Calif. to require Rx reviews for discharges | Amazon cuts 14K corporate jobs | Pa. hospitals report more drug-related seizures

From Tylenol lawsuits to Rx oversight — accountability takes center stage. October 28, 2025 1. What hospitals need from pharmacy leaders Full story 2. Texas sues Tylenol makers, alleging drug's links to autism Full story 3. Modernize your pharmacy strategy. RxSense…

2 gene therapy trials paused | 212 Kan. pharmacy techs push to unionize | Evernorth launches rebate-free pharmacy model | FDA OKs cancer drug previously pulled | 75% of drug shortages last 3+ years

From union drives to rebate-free models — pressure builds across pharmacy. October 27, 2025 1. 212 pharmacy techs at Kansas system seek unionization Full story 2. Intellia halts 2 gene therapy trials after patient hospitalized Full story 3. AI is…

ASHP to Congress: Reject 340B rebate model | 14 pharma execs talk hospital consolidation | 10 systems seeking pharmacy leaders | GLP-1 prescribing plateaus | COVID shot may extend life for some cancer patients

From 340B rebate pushback to GLP-1 plateaus — pharmacy trends in motion. October 23, 2025 1. ASHP urges Congress to preserve 340B program, reject rebate model Full story 2. The pharmacy perspective on hospital consolidation's next chapter Full story 3.…